Atlas Trials

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Clinical trial NCT06265350 · RECRUITING

Trial details

NCT number
NCT06265350
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular CarcinomaLiver Cancer Stage IVPulmonary MetastasesCadonilimabBevacizumabCryoablation
Start date
2024-02-02
Primary completion
2026-01-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.